Restylane Refyne, Restylane Defyne, Restylane Kysse Injectable Gels
FDA premarket approval P140029/S030 · decided 2020-10-14
Approval details
- PMA number
- P140029
- Supplement
- S030
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Restylane Refyne, Restylane Defyne, Restylane Kysse Injectable Gels
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2020-09-14
- Decision date
- 2020-10-14
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Changes to the distribution systems for water for injection (WFI) and compressed air distribution systems at the Uppsala, Sweden manufacturing facility for Restylane Refyne, Restylane Defyne and Restylane Kysse.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.